Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Avid Bioservices (CDMO) stocks in Canada
Learn how to easily invest in Avid Bioservices stocks.
Avid Bioservices is a biotechnology business based in the US. Avid Bioservices stocks (CDMO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $26.62 – a decrease of 13.21% over the previous week. Avid Bioservices employs 252 staff and has a trailing 12-month revenue of around $106.3 million.
How to buy shares in Avid Bioservices
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CDMO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Avid Bioservices?
- Has coronavirus impacted Avid Bioservices shares?
- Avid Bioservices shares summary
- Compare share dealing platforms
- Is Avid Bioservices stock a buy or sell?
- Avid Bioservices performance over time
- Are Avid Bioservices shares over-valued?
- Avid Bioservices's financials
- How volatile are Avid Bioservices shares?
- Does Avid Bioservices pay a dividend?
- Have Avid Bioservices shares ever split?
- Other common questions
Avid Bioservices stock price (NASDAQ:CDMO)Use our graph to track the performance of CDMO stocks over time.
Avid Bioservices shares at a glance
|Latest market close||$18.20|
|52-week range||$12.60 - $34.51|
|50-day moving average||$28.73|
|200-day moving average||$24.67|
|Wall St. target price||$32.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.14|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Avid Bioservices stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Avid Bioservices price performance over time
|1 week (2022-01-13)||-12.25%|
|1 month (2021-12-18)||N/A|
|3 months (2021-10-18)||N/A|
|6 months (2021-07-22)||-28.91%|
|1 year (2021-01-22)||27.72%|
|2 years (2020-01-22)||183.05%|
|3 years (2019-01-22)||405.56%|
|5 years (2017-01-20)||6,226.03%|
Is Avid Bioservices under- or over-valued?
Valuing Avid Bioservices stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avid Bioservices's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avid Bioservices's P/E ratio
Avid Bioservices's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 154x. In other words, Avid Bioservices shares trade at around 154x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Avid Bioservices's EBITDA
Avid Bioservices's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.2 million.
The EBITDA is a measure of a Avid Bioservices's overall financial performance and is widely used to measure a its profitability.
Avid Bioservices financials
|Revenue TTM||$106.3 million|
|Operating margin TTM||15.39%|
|Gross profit TTM||$29.3 million|
|Return on assets TTM||4.92%|
|Return on equity TTM||27.91%|
|Market capitalisation||$1.3 billion|
TTM: trailing 12 months
Avid Bioservices share dividends
We're not expecting Avid Bioservices to pay a dividend over the next 12 months.
Have Avid Bioservices's shares ever split?
Avid Bioservices's shares were split on a 1:7 basis on 9 July 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avid Bioservices shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Avid Bioservices shares which in turn could have impacted Avid Bioservices's share price.
Avid Bioservices share price volatility
Over the last 12 months, Avid Bioservices's shares have ranged in value from as little as $12.6 up to $34.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avid Bioservices's is 2.2955. This would suggest that Avid Bioservices's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Avid Bioservices overview
Avid Bioservices, Inc. , a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc.
Stocks similar to Avid Bioservices
Avid Bioservices in the news
Avid Bioservices (CDMO) Stock Moves -1.67%: What You Should Know
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Frequently asked questions
More guides on Finder
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.